Virtus LifeSci Biotech Products ETF Rating $70.97 +0.17 (+0.24%) Closing price 10/13/2025 04:10 PM EasternExtended Trading$70.96 -0.02 (-0.02%) As of 10/13/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock Virtus LifeSci Biotech Products ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBP Aggregate RatingModerate Buy 2.70Holdings in BBP have an aggregate rating of Moderate Buy based on 321 analyst ratings issued in the past year covering 25 companies (55.8% of the portfolio).BBP Aggregate Price Target$70.97High Prediction$70.97Average Prediction$70.97Low Prediction$70.97Holdings in BBP have an aggregate price target of $70.97 and a range of $70.97 to $70.97 covering 25 companies (55.8% of the portfolio).BBP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Products ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 BBP Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.89%IONSIonis Pharmaceuticals$70.59+0.9%3.4376 of 5 stars2.80$78.28 10.9%202.60%TVTXTravere Therapeutics$26.20+4.1%2.0974 of 5 stars2.73$35.21 34.4%152.51%CRSPCRISPR Therapeutics$68.29-6.5%1.8241 of 5 stars2.42$71.71 5.0%19Analyst Forecast2.48%RYTMRhythm Pharmaceuticals$100.770.0%3.3447 of 5 stars2.94$106.64 5.8%17Positive News2.45%LGNDLigand Pharmaceuticals$179.89+1.2%3.9129 of 5 stars2.71$176.50 -1.9%72.39%UTHRUnited Therapeutics$440.06+0.0%4.2229 of 5 stars2.67$457.21 3.9%15Analyst ForecastInsider Trade2.38%INSMInsmed$163.94+1.0%2.9438 of 5 stars2.86$149.06 -9.1%212.37%ALNYAlnylam Pharmaceuticals$464.95+1.0%3.9719 of 5 stars2.82$457.08 -1.7%28Analyst Forecast2.36%MDGLMadrigal Pharmaceuticals$427.73-0.4%4.4096 of 5 stars2.73$525.88 22.9%11Analyst Forecast2.33%MIRMMirum Pharmaceuticals$72.17-0.7%3.3418 of 5 stars3.00$76.50 6.0%122.25%ARDXArdelyx$5.01+1.4%4.3275 of 5 stars2.91$11.70 133.5%11News Coverage2.19%TARSTarsus Pharmaceuticals$70.34+0.3%0.6814 of 5 stars2.50$66.67 -5.2%82.18%KNSAKiniksa Pharmaceuticals International$37.03-2.3%3.895 of 5 stars2.78$45.43 22.7%9Analyst Forecast2.17%AUPHAurinia Pharmaceuticals$11.10-1.5%3.487 of 5 stars2.67$13.00 17.1%3Positive News2.15%HALOHalozyme Therapeutics$65.33+1.9%4.6705 of 5 stars2.31$70.44 7.8%132.15%ROIVRoivant Sciences$16.21+1.1%3.3557 of 5 stars2.80$19.94 23.0%102.13%TBPHTheravance Biopharma$13.92-0.5%3.1971 of 5 stars3.00$23.00 65.2%62.11%BBIOBridgeBio Pharma$55.96+0.8%4.1442 of 5 stars2.89$63.94 14.3%18Insider Trade2.08%NVAXNovavax$8.62+3.5%4.2364 of 5 stars2.00$12.33 43.1%92.00%KRYSKrystal Biotech$184.74+1.8%4.4962 of 5 stars2.75$209.00 13.1%8Analyst Revision1.96%INCYIncyte$84.73+1.1%4.2808 of 5 stars2.22$84.79 0.1%18Positive News1.95%FOLDAmicus Therapeutics$8.18-1.4%4.5058 of 5 stars2.82$15.78 92.9%111.92%PHATPhathom Pharmaceuticals$12.53+6.0%2.1874 of 5 stars2.71$17.50 39.7%71.90%PTCTPTC Therapeutics$66.06-0.3%3.2633 of 5 stars2.53$69.00 4.5%15Analyst Revision1.90%ONCBeOne Medicines$327.03+2.2%1.6475 of 5 stars2.90$340.30 4.1%10Insider Trade This page (NYSEARCA:BBP) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredThe Army Just Got a New Drone SupplierA cutting-edge drone developer just secured a U.S. Army deal to supply its Flex FPV Modular Drones and build a...The Tomorrow Investor | SponsoredBlackRock’s Shocking Crypto MoveBlackRock, Fidelity, and JPMorgan have quietly shifted billions out of Bitcoin and into a single emerging cryp...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredBuy alert: Move $1,000 before Tesla’s Optimus launchElon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Products ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
